Cargando…
Novel immune‐related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common malignant tumor of the kidney and is characterized by poor prognosis. We sought to build an immune‐related prognostic signature and investigate its relationship with immunotherapy response in ccRCC. METHODS: Immune‐related genes...
Autores principales: | Zhou, Libin, Fang, Hualong, Yin, Min, Long, Huimin, Weng, Guobin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169179/ https://www.ncbi.nlm.nih.gov/pubmed/35441741 http://dx.doi.org/10.1002/jcla.24409 |
Ejemplares similares
-
Computational construction of TME‐related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma
por: Zhou, Libin, et al.
Publicado: (2022) -
Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature
por: Liu, Gang, et al.
Publicado: (2023) -
Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma
por: BAO, WEI, et al.
Publicado: (2023) -
Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma
por: Hua, Xiaoliang, et al.
Publicado: (2020) -
Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy
por: Bai, Dan, et al.
Publicado: (2021)